NASDAQ:BBIO

BridgeBio Pharma Insider Trades

$54.95
-0.80 (-1.43 %)
(As of 04/15/2021 12:00 AM ET)
Add
Compare
Today's Range
$54.23
Now: $54.95
$57.07
50-Day Range
$53.96
MA: $63.25
$71.91
52-Week Range
$25.24
Now: $54.95
$73.50
Volume814,516 shs
Average Volume1.03 million shs
Market Capitalization$8.19 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.82

Insider Trades

BridgeBio Pharma (NASDAQ:BBIO) Insider Buying and Selling Activity

Insider Ownership Percentage: 40.32%
Insider Buying (Last 12 Months): $1,500,000.00
Insider Selling (Last 12 Months): $308,012,753.00

Insider Buying and Selling by Quarter


BridgeBio Pharma (NASDAQ BBIO) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/17/2021Brian C. StephensonInsiderBuy8,000$62.50$500,000.00  
2/17/2021Genetic Disorder L.P. KkrMajor ShareholderSell3,450,000$60.47$208,621,500.00  
2/17/2021Randal W ScottDirectorBuy16,000$62.50$1,000,000.0021,000  
12/28/2020Cameron TurtleInsiderSell19,500$69.60$1,357,200.0020,068  
12/21/2020Richard H SchellerInsiderSell60,401$65.32$3,945,393.3291,333  
12/1/2020Michael Thomas HendersonInsiderSell10,000$51.52$515,200.00284,211  
11/25/2020Cameron TurtleInsiderSell742$47.23$35,044.6616,826  
11/16/2020Michael Thomas HendersonInsiderSell10,000$45.00$450,000.00277,751  
11/5/2020Cameron TurtleInsiderSell2,500$42.05$105,125.0015,068  
11/2/2020Michael Thomas HendersonInsiderSell10,000$38.36$383,600.00277,751  
10/16/2020Charles J HomcyChairmanSell10,256$41.00$420,496.001,214,023  
9/30/2020Cameron TurtleInsiderSell14,500$37.69$546,505.0015,068  
9/29/2020Charles J. HomcyChairmanSell18,200$37.50$682,500.001,213,767  
9/25/2020Charles J. HomcyChairmanSell81,057$36.83$2,985,329.31  
9/18/2020Cameron TurtleInsiderSell2,500$42.01$105,025.0015,068  
9/15/2020Cameron TurtleInsiderSell2,500$37.06$92,650.0015,068  
8/3/2020Brian C StephensonInsiderSell4,661$27.27$127,105.47289,855  
8/3/2020Neil KumarCEOSell66,057$27.27$1,801,374.394,685,725  
7/1/2020Neil KumarCEOSell87,025$31.09$2,705,607.254,685,725  
6/30/2020Cameron TurtleInsiderSell10,000$32.66$326,600.0015,823  
6/3/2020Brian C StephensonInsiderSell1,600$30.04$48,064.00307,116  
6/3/2020Neil KumarCEOSell5,930$30.05$178,196.504,685,725  
5/28/2020Genetic Disorder L.P. KkrMajor ShareholderSell2,389,690$33.39$79,791,749.10  
5/5/2020Neil KumarCEOSell79,600$31.02$2,469,192.004,685,725  
5/4/2020Brian C StephensonInsiderSell1,494$30.00$44,820.00324,316  
5/1/2020Brian C StephensonInsiderSell7,200$29.23$210,456.00324,316  
4/27/2020Cameron TurtleInsiderSell2,000$32.01$64,020.0011,823  
4/8/2020Cameron TurtleInsiderSell8,000$27.04$216,320.0017,823  
4/7/2020Neil KumarCEOSell1,805$25.48$45,991.404,685,725  
4/3/2020Neil KumarCEOSell300$25.09$7,527.004,685,725  
4/1/2020Michael Thomas HendersonInsiderSell2,585$26.94$69,639.90170,268  
4/1/2020Neil KumarCEOSell62,117$26.26$1,631,192.424,685,725  
2/11/2020Cameron TurtleInsiderSell2,000$37.28$74,560.0011,823  
2/10/2020Charles J HomcyChairmanSell20,000$36.00$720,000.001,342,291  
2/5/2020Neil KumarCEOSell30,893$34.87$1,077,238.914,685,365  
1/14/2020Charles J. HomcyChairmanSell10,000$35.00$350,000.00  
1/8/2020Cameron TurtleInsiderSell12,807$34.37$440,176.5922,630  
1/2/2020Michael Thomas HendersonInsiderSell3,617$33.26$120,301.42  
12/30/2019Frank MccormickChairmanSell17,150$35.80$613,970.001,335,895  
12/27/2019Frank MccormickChairmanSell82,850$37.92$3,141,672.001,335,895  
7/1/2019Brian C StephensonInsiderBuy55,500$17.00$943,500.00  
7/1/2019Genetic Disorder L.P. KkrMajor ShareholderBuy2,647,100$17.00$45,000,700.00  
6/28/2019Michael Thomas HendersonInsiderBuy1,000$3.43$3,430.00
6/27/2019Global Investors Lp VikingMajor ShareholderBuy4,705,900$17.00$80,000,300.00  
(Data available from 1/1/2013 forward)
This page was last updated on 4/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.